4//SEC Filing
Knowles Julius 4
Accession 0001808365-25-000005
CIK 0001664710other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:15 PM ET
Size
8.0 KB
Accession
0001808365-25-000005
Insider Transaction Report
Form 4
Knowles Julius
Director
Transactions
- Disposition to Issuer
Common Stock
2025-11-21$17.75/sh−191,527$3,399,604→ 150,047 total(indirect: See footnote) - Disposition to Issuer
Common Stock
2025-11-21$17.75/sh−130,494$2,316,269→ 102,233 total(indirect: See footnote)
Holdings
- 6,441
Common Stock
Footnotes (3)
- [F1]Represents shares tendered and accepted for purchase by the Issuer in a cash tender offer commenced by the Issuer on October 20, 2025. The Issuer announced the final results of the tender offer on November 20, 2025.
- [F2]The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF I.
- [F3]The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF II.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001808365
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:15 PM ET
- Size
- 8.0 KB